SBC Medical Group
SBC | NASDAQ
$5.14
+$0.39 (+8.21%)
At close: Sep 21, 2026, 4:00 PM ET
$5.24
+$0.10 (+1.95%)
Pre-market:
Sep 22, 2026, 4:43 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 49.19M | 43.06M | 39.57M | 43.35M | 43.36M | 47.33M | 44.42M | 53.08M | 53.1M | 54.81M | 62.35M | 47.28M | 41M | 42.91M |
Cost of Revenue | 13.21M | 13.02M | 10.64M | 13.45M | 13.35M | 9.6M | 10.55M | 9.85M | 13.68M | 15.29M | 18.98M | 13.78M | 9.08M | 14.4M |
Gross Profit | 35.98M | 30.04M | 28.93M | 29.9M | 30.01M | 37.73M | 33.87M | 43.24M | 39.42M | 39.52M | 43.37M | 33.5M | 31.92M | 28.52M |
Operating Income | 18.96M | 17.72M | 12.85M | 15.88M | 14.55M | 24.2M | 4.72M | 13.83M | 27.29M | 24.46M | 23.99M | 20.02M | 15.57M | 11.08M |
Interest Income | 8.52K | 121.37K | -284 | 120.38K | 22.88K | 55.33K | n/a | 7.95K | 11.64K | 17.69K | 403 | 10.23K | n/a | 57.61K |
Pretax Income | 19.55M | 18.86M | 18.57M | 18.51M | 13.54M | 31.45M | 6.06M | 13.11M | 27.09M | 27.2M | 23.57M | 21.07M | 16.67M | 12.27M |
Net Income | 10.69M | 11.31M | 14.2M | 12.82M | 2.46M | 21.5M | 6.54M | 2.83M | 18.48M | 18.76M | 14.34M | 8.36M | 10.67M | 6M |
Selling & General & Admin | 17.02M | 12.32M | 18.63M | 13.95M | 14.39M | 12.82M | 13.9M | 29.25M | 11.83M | 14.96M | 19.35M | 13.45M | 16.19M | 17.25M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | -2.55M | 70.77K | 1.06M | 706.87K | 15.25M | 151.61K | 300.89K | 100.06K | 28.26K | 28.52K | 160.2K | 192.05K |
Operating Expenses | 17.02M | 12.32M | 16.08M | 14.02M | 15.46M | 13.53M | 29.15M | 29.4M | 12.13M | 15.06M | 19.38M | 13.48M | 16.35M | 17.44M |
Interest Expense | 128.63K | 114.81K | 56.09K | 48.64K | 49.65K | 6.21K | 12.4K | 5.47K | 7.42K | 3.01K | 7.91K | 3.98K | 14.9K | n/a |
Selling & Marketing Expenses | n/a | n/a | -1.96M | 300.68K | 973.93K | 682.17K | 1.23M | 621.76K | 844.85K | 711.63K | n/a | n/a | n/a | n/a |
Cost & Expenses | 30.23M | 25.34M | 26.72M | 27.47M | 28.8M | 23.13M | 39.7M | 39.25M | 25.81M | 30.35M | 38.36M | 27.26M | 25.43M | 31.84M |
Income Tax Expense | 7.82M | 7.53M | 4.29M | 5.67M | 11.1M | 9.96M | -488.55K | 10.27M | 8.53M | 8.45M | 9.34M | 13.01M | 6.81M | 5.86M |
Shares Outstanding (Basic) | 102.58M | 102.58M | 102.58M | 102.64M | 103.51M | 103.28M | 102.75M | 95.1M | 94.19M | 94.19M | 94.19M | 94.19M | 9.49M | 15.07M |
Shares Outstanding (Diluted) | 102.58M | 102.58M | 102.58M | 102.64M | 103.51M | 103.28M | 102.75M | 95.1M | 94.19M | 94.19M | 94.19M | 94.19M | 9.49M | 15.07M |
EPS (Basic) | 0.10 | 0.11 | 0.14 | 0.12 | 0.02 | 0.21 | 0.06 | 0.03 | 0.20 | 0.20 | 0.15 | 0.09 | 0.02 | 0.04 |
EPS (Diluted) | 0.10 | 0.11 | 0.14 | 0.12 | 0.02 | 0.21 | 0.06 | 0.03 | 0.20 | 0.20 | 0.15 | 0.09 | 0.02 | 0.04 |
EBITDA | 18.25M | 19.64M | 19.3M | 19.27M | 14.23M | 32.09M | 7M | 14.13M | 27.92M | 28.22M | 26.13M | 24.36M | 20.29M | 15.07M |
EBIT | 18.25M | 18.97M | 18.62M | 18.56M | 13.59M | 31.46M | 6.07M | 13.11M | 27.09M | 27.21M | 23.57M | 21.07M | 16.68M | 12.27M |
Depreciation & Amortization | n/a | 670.43K | 673.68K | 714.75K | 636.1K | 628.3K | 931.6K | 1.02M | 830.95K | 1.02M | 2.56M | 3.29M | 3.6M | 2.8M |
Add to Watchlist
Select watchlists to add or remove SBC